Skip to main content

Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1619))

Abstract

Blood protein measurements are used frequently in the clinic in the assessment of patient health. Nevertheless, there remains the need for new biomarkers with better diagnostic specificities. With the advent of improved technology for bioanalysis and the growth of biobanks including collections from specific disease risk cohorts, the plasma proteome has remained a target of proteomics research toward the characterization of disease-related biomarkers. The following protocol presents a workflow for serum/plasma proteomics including details of sample preparation both with and without immunoaffinity depletion of the most abundant plasma proteins and methodology for selected reaction monitoring mass spectrometry validation.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS (2005) Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 4:409–418

    Article  CAS  PubMed  Google Scholar 

  2. Lyons TJ, Basu A (2012) Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. Transl Res 159:303–312

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Crutchfield CA, Thomas SN, Sokoll LJ, Chan DW (2016) Advances in mass spectrometry-based clinical biomarker discovery. Clin Proteomics 13:1

    Article  PubMed  PubMed Central  Google Scholar 

  4. Dayon L, Kussmann M (2013) Proteomics of human plasma: a critical comparison of analytical workflows in terms of effort, throughput and outcome. EuPA Open Proteom 1:8–16

    Article  CAS  Google Scholar 

  5. Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971–983

    Article  CAS  PubMed  Google Scholar 

  6. Surinova S, Schiess R, Hüttenhain R, Cerciello F, Wollscheid B, Aebersold R (2011) On the development of plasma protein biomarkers. J Proteome Res 10:5–16

    Article  CAS  PubMed  Google Scholar 

  7. Picotti P, Aebersold R (2012) Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 9:555–566

    Article  CAS  PubMed  Google Scholar 

  8. Lange V, Picotti P, Domon B, Aebersold R (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4:222

    Article  PubMed  PubMed Central  Google Scholar 

  9. Escher C, Reiter L, MacLean B, Ossola R, Herzog F, Chilton J, MacCoss MJ, Rinner O (2012) Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 12(8):1111–1121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Issaq HJ, Xiao Z, Veenstra TD (2007) Serum and plasma proteomics. Chem Rev 107(8):3601–3620

    Article  CAS  PubMed  Google Scholar 

  11. Tu C, Rudnick PA, Martinez MY, Cheek KL, Stein SE, Slebos RJ, Liebler DC (2010) Depletion of abundant plasma proteins and limitations of plasma proteomics. J Proteome Res 9(10):4982–4991

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Geyer PE, Kulak NA, Pichler G, Holdt LM, Teupser D, Mann M (2016) Plasma proteome profiling to assess human health and disease. Cell Syst 2(3):185–195

    Article  CAS  PubMed  Google Scholar 

  13. Ahmed N, Barker G, Oliva K, Garfin D, Talmadge K, Georgiou H, Quinn M, Rice G (2003) An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. Proteomics 3(10):1980–1987

    Article  CAS  PubMed  Google Scholar 

  14. Smith MP, Wood SL, Zougman A, Ho JT, Peng J, Jackson D, Cairns DA, Lewington AJ, Selby PJ, Banks RE (2011) A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses. Proteomics 11(11):2222–2235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Moulder R, Goo YA, Goodlett DR (2016) Label-free quantitation for clinical proteomics. Methods Mol Biol 1410:65–76

    Article  PubMed  Google Scholar 

  16. Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367–1372

    Article  CAS  PubMed  Google Scholar 

  17. Megger DA, Bracht T, Kohl M, Ahrens M, Naboulsi W, Weber F, Hoffmann AC, Stephan C, Kuhlmann K, Eisenacher M, Schlaak JF, Baba HA, Meyer HE, Sitek B (2013) Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study. Mol Cell Proteomics 12:2006–2020

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10:794–1805

    Article  Google Scholar 

  19. Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, Mann M, Cox J (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13(9):731–740

    Article  CAS  PubMed  Google Scholar 

  20. Tyanova S, Mann M, Cox J (2014) MaxQuant for in-depth analysis of large SILAC datasets. Methods Mol Biol 1188:351–364

    Article  PubMed  Google Scholar 

  21. Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13:2513–2526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. R Development Core Team (2011) R: a language and environment for statistical computing, Vienna, Austria

    Google Scholar 

  23. IBM Corp. Released 2013. IBM SPSS statistics for windows version 22.0. IBM Corp., Armonk, NY

    Google Scholar 

  24. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26:966–968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Brusniak MK, Kwok S, Christiansen M, Campbell D, Reiter L, Picotti P, Kusebauch U, Ramos H, Deutsch EW, Chen J, Moritz RL, Aebersold R (2011) ATAQS: A computational software tool for high throughput transition optimization and validation for selected reaction monitoring mass spectrometry. BMC Bioinformatics 12:78

    Article  PubMed  PubMed Central  Google Scholar 

  26. Teleman J, Karlsson C, Waldemarson S, Hansson K, James P, Malmström J, Levander F (2012) Automated selected reaction monitoring software for accurate label-free protein quantification. J Proteome Res 11(7):3766–3773

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Aiyetan P, Thomas SN, Zhang Z, Zhang H (2015) MRMPlus: an open source quality control and assessment tool for SRM/MRM assay development. BMC Bioinformatics 16:411

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgment

The National Technology Agency of Finland (Finland Distinguished Professor Programme, grant 40398/11), the Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research, grant 250114), JDRF, the Sigrid Jusélius Foundation, and Biocentre Finland (Turku Proteomics Facility) are thanked for their financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David R. Goodlett .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Bhosale, S.D., Moulder, R., Kouvonen, P., Lahesmaa, R., Goodlett, D.R. (2017). Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation. In: Greening, D., Simpson, R. (eds) Serum/Plasma Proteomics. Methods in Molecular Biology, vol 1619. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7057-5_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7057-5_31

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7056-8

  • Online ISBN: 978-1-4939-7057-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics